{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:21:18Z","timestamp":1786980078863,"version":"build-2736575974"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:00:00Z","timestamp":1656460800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:00:00Z","timestamp":1656460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s00393-022-01229-x","type":"journal-article","created":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T05:07:57Z","timestamp":1656479277000},"page":"549-557","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Immunglobulin-G4-assoziierte Erkrankung","Immunoglobulin-G4-related disease"],"prefix":"10.1007","volume":"81","author":[{"given":"Jasper F.","family":"Nies","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0582-7790","authenticated-orcid":false,"given":"Martin","family":"Krusche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,29]]},"reference":[{"key":"1229_CR1","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1365-2222.2009.03207.x","volume":"39","author":"RC Aalberse","year":"2009","unstructured":"Aalberse\u00a0RC, Stapel\u00a0SO, Schuurman\u00a0J et\u00a0al (2009) Immunoglobulin G4: an odd antibody. Clin Exp Allergy 39:469\u2013477","journal-title":"Clin Exp Allergy"},{"key":"1229_CR2","doi-asserted-by":"publisher","first-page":"e3970","DOI":"10.1097\/MD.0000000000003970","volume":"95","author":"M Akiyama","year":"2016","unstructured":"Akiyama\u00a0M, Kaneko\u00a0Y, Hayashi\u00a0Y et al (2016) IgG4-related disease involving vital organs diagnosed with lip biopsy: a case report and literature review. Medicine 95:e3970","journal-title":"Medicine"},{"key":"1229_CR3","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1002\/art.39209","volume":"67","author":"M Akiyama","year":"2015","unstructured":"Akiyama\u00a0M, Suzuki\u00a0K, Yamaoka\u00a0K et al (2015) Number of circulating follicular helper 2\u202fT cells correlates with IgG4 and Interleukin\u20114 levels and plasmablast numbers in IgG4-related disease. Arthritis Rheumatol 67:2476\u20132481","journal-title":"Arthritis Rheumatol"},{"key":"1229_CR4","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.neurad.2021.01.006","volume":"48","author":"F Behzadi","year":"2021","unstructured":"Behzadi\u00a0F, Suh\u00a0CH, Jo\u00a0VY et al (2021) Imaging of IgG4-related disease in the head and neck: a systematic review, case series, and pathophysiology update. J\u00a0Neuroradiol 48:369\u2013378","journal-title":"J Neuroradiol"},{"key":"1229_CR5","doi-asserted-by":"publisher","first-page":"e4002","DOI":"10.1097\/MD.0000000000004002","volume":"95","author":"P Brito-Zeron","year":"2016","unstructured":"Brito-Zeron\u00a0P, Kostov\u00a0B, Bosch\u00a0X et al (2016) Therapeutic approach to IgG4-related disease: a systematic review. Medicine 95:e4002","journal-title":"Medicine"},{"key":"1229_CR6","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3109\/03009742.2015.1055796","volume":"45","author":"C Campochiaro","year":"2016","unstructured":"Campochiaro\u00a0C, Ramirez\u00a0GA, Bozzolo\u00a0EP et al (2016) IgG4-related disease in Italy: clinical features and outcomes of a\u00a0large cohort of patients. Scand J Rheumatol 45:135\u2013145","journal-title":"Scand J Rheumatol"},{"key":"1229_CR7","doi-asserted-by":"publisher","first-page":"259408","DOI":"10.1155\/2012\/259408","volume":"2012","author":"MN Carruthers","year":"2012","unstructured":"Carruthers\u00a0MN, Stone\u00a0JH, Deshpande\u00a0V et al (2012) Development of an IgG4-RD responder index. Int J Rheumatol 2012:259408","journal-title":"Int J Rheumatol"},{"key":"1229_CR8","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1136\/annrheumdis-2014-206605","volume":"74","author":"MN Carruthers","year":"2015","unstructured":"Carruthers\u00a0MN, Topazian\u00a0MD, Khosroshahi\u00a0A et al (2015) Rituximab for IgG4-related disease: a\u00a0prospective, open-label trial. Ann Rheum Dis 74:1171\u20131177","journal-title":"Ann Rheum Dis"},{"key":"1229_CR9","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1002\/art.40556","volume":"70","author":"Y Chen","year":"2018","unstructured":"Chen\u00a0Y, Lin\u00a0W, Yang\u00a0H et al (2018) Aberrant expansion and function of follicular helper T cell subsets in IgG4-related disease. Arthritis Rheumatol 70:1853\u20131865","journal-title":"Arthritis Rheumatol"},{"key":"1229_CR10","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.autrev.2017.07.020","volume":"16","author":"FX Danlos","year":"2017","unstructured":"Danlos\u00a0FX, Rossi\u00a0GM, Blockmans\u00a0D et al (2017) Antineutrophil cytoplasmic antibody-associated vasculitides and IgG4-related disease: a new overlap syndrome. Autoimmun Rev 16:1036\u20131043","journal-title":"Autoimmun Rev"},{"key":"1229_CR11","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1002\/art.40469","volume":"70","author":"E Della-Torre","year":"2018","unstructured":"Della-Torre\u00a0E, Bozzalla-Cassione\u00a0E, Sciorati\u00a0C et al (2018) A CD8alpha-subset of CD4+SLAMF7+ Cytotoxic T cells is expanded in patients with IgG4-related disease and decreases following glucocorticoid treatment. Arthritis Rheumatol 70:1133\u20131143","journal-title":"Arthritis Rheumatol"},{"key":"1229_CR12","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.jaci.2019.07.004","volume":"145","author":"E Della-Torre","year":"2020","unstructured":"Della-Torre\u00a0E, Rigamonti\u00a0E, Perugino\u00a0C et al (2020) B lymphocytes directly contribute to tissue fibrosis in patients with IgG4-related disease. J\u00a0Allergy Clin Immunol 145:968\u2013981.e14","journal-title":"J Allergy Clin Immunol"},{"key":"1229_CR13","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/modpathol.2012.72","volume":"25","author":"V Deshpande","year":"2012","unstructured":"Deshpande\u00a0V, Zen\u00a0Y, Chan\u00a0JK et al (2012) Consensus statement on the pathology of IgG4-related disease. Mod Pathol 25:1181\u20131192","journal-title":"Mod Pathol"},{"key":"1229_CR14","doi-asserted-by":"publisher","first-page":"602809","DOI":"10.1155\/2012\/602809","volume":"2012","author":"M Ebbo","year":"2012","unstructured":"Ebbo\u00a0M, Grados\u00a0A, Bernit\u00a0E et\u00a0al (2012) Pathologies associated with serum IgG4 elevation. Int J Rheumatol 2012:602809","journal-title":"Int J Rheumatol"},{"key":"1229_CR15","doi-asserted-by":"publisher","first-page":"42413","DOI":"10.1038\/srep42413","volume":"7","author":"S Furukawa","year":"2017","unstructured":"Furukawa\u00a0S, Moriyama\u00a0M, Miyake\u00a0K et al (2017) Interleukin-33 produced by M2 macrophages and other immune cells contributes to Th2 immune reaction of IgG4-related disease. Sci Rep 7:42413","journal-title":"Sci Rep"},{"key":"1229_CR16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.clim.2014.10.008","volume":"156","author":"S Furukawa","year":"2015","unstructured":"Furukawa\u00a0S, Moriyama\u00a0M, Tanaka\u00a0A et al (2015) Preferential M2 macrophages contribute to fibrosis in IgG4-related dacryoadenitis and sialoadenitis, so-called Mikulicz\u2019s disease. Clin Immunol 156:9\u201318","journal-title":"Clin Immunol"},{"key":"1229_CR17","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1056\/NEJM200103083441005","volume":"344","author":"H Hamano","year":"2001","unstructured":"Hamano\u00a0H, Kawa\u00a0S, Horiuchi\u00a0A et\u00a0al (2001) High serum IgG4 concentrations in patients with sclerosing pancreatitis. N\u00a0Engl J Med 344:732\u2013738","journal-title":"N Engl J Med"},{"key":"1229_CR18","first-page":"728","volume":"67","author":"LM Hubers","year":"2018","unstructured":"Hubers\u00a0LM, Vos\u00a0H, Schuurman\u00a0AR et al (2018) Annexin A11 is targeted by IgG4 and IgG1 autoantibodies in IgG4-related disease. Gut 67:728\u2013735","journal-title":"Gut"},{"key":"1229_CR19","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/qq9qup","author":"L Iaccarino","year":"2022","unstructured":"Iaccarino L, Talarico R, Bozzalla-Cassione E et al (2022) Blood biomarkers recommended for diagnosing and monitoring IgG4-related disease. Considerations from the ERN ReCONNET and collaborating partners. Clin Exp Rheumatol. https:\/\/doi.org\/10.55563\/clinexprheumatol\/qq9qup","journal-title":"Clin Exp Rheumatol"},{"key":"1229_CR20","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.imlet.2019.01.008","volume":"207","author":"F Ito","year":"2019","unstructured":"Ito\u00a0F, Kamekura\u00a0R, Yamamoto\u00a0M et al (2019) IL-10(+) T follicular regulatory cells are associated with the pathogenesis of IgG4-related disease. Immunol Lett 207:56\u201363","journal-title":"Immunol Lett"},{"key":"1229_CR21","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.3906\/sag-2006-375","volume":"50","author":"H Karadeniz","year":"2020","unstructured":"Karadeniz\u00a0H, Vaglio\u00a0A (2020) IgG4-related disease: a\u00a0contemporary review. Turk J Med Sci 50:1616\u20131631","journal-title":"Turk J Med Sci"},{"key":"1229_CR22","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12969-016-0079-3","volume":"14","author":"F Karim","year":"2016","unstructured":"Karim\u00a0F, Loeffen\u00a0J, Bramer\u00a0W et al (2016) IgG4-related disease: a\u00a0systematic review of this unrecognized disease in pediatrics. Pediatr Rheumatol Online\u00a0J 14:18","journal-title":"Pediatr Rheumatol Online J"},{"key":"1229_CR23","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1093\/ndt\/gfy296","volume":"34","author":"T Kawakami","year":"2019","unstructured":"Kawakami\u00a0T, Mizushima\u00a0I, Yamada\u00a0K et al (2019) Abundant a\u00a0proliferation-inducing ligand (APRIL)-producing macrophages contribute to plasma cell accumulation in immunoglobulin G4-related disease. Nephrol Dial Transplant 34:960\u2013969","journal-title":"Nephrol Dial Transplant"},{"key":"1229_CR24","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1002\/art.39132","volume":"67","author":"A Khosroshahi","year":"2015","unstructured":"Khosroshahi\u00a0A, Wallace\u00a0ZS, Crowe\u00a0JL et al (2015) International consensus guidance statement on the management and treatment of IgG4-related disease. Arthritis Rheumatol 67:1688\u20131699","journal-title":"Arthritis Rheumatol"},{"key":"1229_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2021-002086","author":"S Kubo","year":"2022","unstructured":"Kubo S, Kanda R, Nawata A et al (2022) Eosinophilic granulomatosis with polyangiitis exhibits T cell activation and IgG4 immune response in the tissue; comparison with IgG4-related disease. Rmd Open. https:\/\/doi.org\/10.1136\/rmdopen-2021-002086","journal-title":"Rmd Open"},{"key":"1229_CR26","first-page":"85","volume":"401","author":"M Lanzillotta","year":"2017","unstructured":"Lanzillotta\u00a0M, Della-Torre\u00a0E, Stone\u00a0JH (2017) Roles of plasmablasts and B cells in IgG4-related disease: implications for therapy and early treatment outcomes. Curr Top Microbiol Immunol 401:85\u201392","journal-title":"Curr Top Microbiol Immunol"},{"key":"1229_CR27","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.201800050","author":"T Maehara","year":"2018","unstructured":"Maehara T, Mattoo H, Mahajan VS et al (2018) The expansion in lymphoid organs of IL-4(+) BATF(+) T follicular helper cells is linked to IgG4 class switching in vivo. Life Sci Alliance. https:\/\/doi.org\/10.26508\/lsa.201800050","journal-title":"Life Sci Alliance"},{"key":"1229_CR28","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1002\/hep.26232","volume":"57","author":"LJ Maillette De Buy Wenniger","year":"2013","unstructured":"Maillette De Buy Wenniger\u00a0LJ, Doorenspleet\u00a0ME, Klarenbeek\u00a0PL et al (2013) Immunoglobulin G4+ clones identified by next-generation sequencing dominate the B cell receptor repertoire in immunoglobulin G4 associated cholangitis. Hepatology 57:2390\u20132398","journal-title":"Hepatology"},{"key":"1229_CR29","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1136\/annrheumdis-2020-218843","volume":"80","author":"B Manger","year":"2021","unstructured":"Manger\u00a0B, Schett\u00a0G (2021) Jan Mikulicz-Radecki (1850\u20131905): return of the surgeon. Ann Rheum Dis 80:8\u201310","journal-title":"Ann Rheum Dis"},{"key":"1229_CR30","doi-asserted-by":"publisher","first-page":"3845","DOI":"10.1093\/rheumatology\/keab124","volume":"60","author":"E Mart\u00edn-Nares","year":"2021","unstructured":"Mart\u00edn-Nares\u00a0E, Hernandez-Molina\u00a0G (2021) What is the meaning of ANCA positivity in IgG4-related disease? Rheumatology 60:3845\u20133850","journal-title":"Rheumatology"},{"key":"1229_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.787422","author":"M Maslinska","year":"2022","unstructured":"Maslinska M, Dmowska-Chalaba J, Jakubaszek M (2022) The role of IgG4 in autoimmunity and rheumatic diseases. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2021.787422","journal-title":"Front Immunol"},{"key":"1229_CR32","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.jaci.2014.03.034","volume":"134","author":"H Mattoo","year":"2014","unstructured":"Mattoo\u00a0H, Mahajan\u00a0VS, Della-Torre\u00a0E et al (2014) De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease. J\u00a0Allergy Clin Immunol 134:679\u2013687","journal-title":"J Allergy Clin Immunol"},{"key":"1229_CR33","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.jaci.2015.12.1330","volume":"138","author":"H Mattoo","year":"2016","unstructured":"Mattoo\u00a0H, Mahajan\u00a0VS, Maehara\u00a0T et al (2016) Clonal expansion of CD4(+) cytotoxic T lymphocytes in patients with IgG4-related disease. J\u00a0Allergy Clin Immunol 138:825\u2013838","journal-title":"J Allergy Clin Immunol"},{"key":"1229_CR34","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/08916934.2017.1280029","volume":"50","author":"H Mattoo","year":"2017","unstructured":"Mattoo\u00a0H, Stone\u00a0JH, Pillai\u00a0S (2017) Clonally expanded cytotoxic CD4(+) T cells and the pathogenesis of IgG4-related disease. Autoimmunity 50:19\u201324","journal-title":"Autoimmunity"},{"key":"1229_CR35","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.jaci.2018.05.011","volume":"143","author":"CA Perugino","year":"2019","unstructured":"Perugino\u00a0CA, Alsalem\u00a0SB, Mattoo\u00a0H et al (2019) Identification of galectin\u20113 as an autoantigen in patients with IgG4-related disease. J\u00a0Allergy Clin Immunol 143:736\u2013745.e6","journal-title":"J Allergy Clin Immunol"},{"key":"1229_CR36","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/s41584-020-0500-7","volume":"16","author":"CA Perugino","year":"2020","unstructured":"Perugino\u00a0CA, Stone\u00a0JH (2020) IgG4-related disease: an update on pathophysiology and implications for clinical care. Nat Rev Rheumatol 16:702\u2013714","journal-title":"Nat Rev Rheumatol"},{"issue":"Suppl 112","key":"1229_CR37","first-page":"186","volume":"36","author":"T Sasaki","year":"2018","unstructured":"Sasaki\u00a0T, Akiyama\u00a0M, Kaneko\u00a0Y et al (2018) Risk factors of relapse following glucocorticoid tapering in IgG4-related disease. Clin Exp Rheumatol 36(Suppl 112):186\u2013189","journal-title":"Clin Exp Rheumatol"},{"key":"1229_CR38","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1136\/annrheumdis-2020-217408","volume":"79","author":"C Schmidkonz","year":"2020","unstructured":"Schmidkonz\u00a0C, Rauber\u00a0S, Atzinger\u00a0A et\u00a0al (2020) Disentangling inflammatory from fibrotic disease activity by fibroblast activation protein imaging. Ann Rheum Dis 79:1485\u20131491","journal-title":"Ann Rheum Dis"},{"key":"1229_CR39","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaq0997","author":"M Shiokawa","year":"2018","unstructured":"Shiokawa M, Kodama Y, Sekiguchi K et\u00a0al (2018) Laminin 511 is a\u00a0target antigen in autoimmune pancreatitis. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.aaq0997","journal-title":"Sci Transl Med"},{"key":"1229_CR40","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1136\/jcp.2010.085613","volume":"64","author":"JD Strehl","year":"2011","unstructured":"Strehl\u00a0JD, Hartmann\u00a0A, Agaimy\u00a0A (2011) Numerous IgG4-positive plasma cells are ubiquitous in diverse localised non-specific chronic inflammatory conditions and need to be distinguished from IgG4-related systemic disorders. J\u00a0Clin Pathol 64:237\u2013243","journal-title":"J Clin Pathol"},{"key":"1229_CR41","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s13244-018-0618-1","volume":"9","author":"CSW Tang","year":"2018","unstructured":"Tang\u00a0CSW, Sivarasan\u00a0N, Griffin\u00a0N (2018) Abdominal manifestations of IgG4-related disease: a\u00a0pictorial review. Insights Imaging 9:437\u2013448","journal-title":"Insights Imaging"},{"key":"1229_CR42","first-page":"358371","volume":"2012","author":"K Uchida","year":"2012","unstructured":"Uchida\u00a0K, Masamune\u00a0A, Shimosegawa\u00a0T et al (2012) Prevalence of IgG4-related disease in Japan based on nationwide survey in 2009. Int J Rheumatol 2012:358371","journal-title":"Int J Rheumatol"},{"key":"1229_CR43","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1002\/art.39205","volume":"67","author":"ZS Wallace","year":"2015","unstructured":"Wallace\u00a0ZS, Deshpande\u00a0V, Mattoo\u00a0H et al (2015) IgG4-related disease: clinical and laboratory features in one hundred twenty-five patients. Arthritis Rheumatol 67:2466\u20132475","journal-title":"Arthritis Rheumatol"},{"key":"1229_CR44","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1002\/acr.23543","volume":"70","author":"ZS Wallace","year":"2018","unstructured":"Wallace\u00a0ZS, Khosroshahi\u00a0A, Carruthers\u00a0MD et al (2018) An international multispecialty validation study of the IgG4-related disease responder index. Arthritis Care Res 70:1671\u20131678","journal-title":"Arthritis Care Res"},{"key":"1229_CR45","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1136\/annrheumdis-2014-205233","volume":"74","author":"ZS Wallace","year":"2015","unstructured":"Wallace\u00a0ZS, Mattoo\u00a0H, Carruthers\u00a0M et al (2015) Plasmablasts as a\u00a0biomarker for IgG4-related disease, independent of serum IgG4 concentrations. Ann Rheum Dis 74:190\u2013195","journal-title":"Ann Rheum Dis"},{"key":"1229_CR46","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1093\/rheumatology\/kev438","volume":"55","author":"ZS Wallace","year":"2016","unstructured":"Wallace\u00a0ZS, Mattoo\u00a0H, Mahajan\u00a0VS et al (2016) Predictors of disease relapse in IgG4-related disease following rituximab. Rheumatology 55:1000\u20131008","journal-title":"Rheumatology"},{"key":"1229_CR47","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/art.41120","volume":"72","author":"ZS Wallace","year":"2020","unstructured":"Wallace\u00a0ZS, Naden\u00a0RP, Chari\u00a0S et al (2020) The 2019 American college of rheumatology\/European league against rheumatism classification criteria for IgG4-related disease. Arthritis Rheumatol 72:7\u201319","journal-title":"Arthritis Rheumatol"},{"key":"1229_CR48","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1136\/annrheumdis-2018-214603","volume":"78","author":"ZS Wallace","year":"2019","unstructured":"Wallace\u00a0ZS, Zhang\u00a0Y, Perugino\u00a0CA et al (2019) Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts. Ann Rheum Dis 78:406\u2013412","journal-title":"Ann Rheum Dis"},{"key":"1229_CR49","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1093\/rheumatology\/key397","volume":"58","author":"L Wang","year":"2019","unstructured":"Wang\u00a0L, Zhang\u00a0P, Zhang\u00a0X et al (2019) Sex disparities in clinical characteristics and prognosis of immunoglobulin G4-related disease: a\u00a0prospective study of 403\u00a0patients. Rheumatology 58:820\u2013830","journal-title":"Rheumatology"},{"key":"1229_CR50","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13075-021-02652-2","volume":"24","author":"T Yu","year":"2022","unstructured":"Yu\u00a0T, Wu\u00a0Y, Liu\u00a0J et al (2022) The risk of malignancy in patients with IgG4-related disease: a\u00a0systematic review and meta-analysis. Arthritis Res Ther 24:14","journal-title":"Arthritis Res Ther"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-022-01229-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00393-022-01229-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-022-01229-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T03:09:24Z","timestamp":1662952164000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00393-022-01229-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,29]]},"references-count":50,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["1229"],"URL":"https:\/\/doi.org\/10.1007\/s00393-022-01229-x","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,29]]},"assertion":[{"value":"5 May 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"J.F.\u00a0Nies und M.\u00a0Krusche geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}